When it comes to continuous measurement of colonoscopy quality, patient survival is mandatory

Affiliations

¹ Department of Cancer Prevention and Department of Oncological Gastroenterology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw, Poland.
² Department of Cancer Prevention and Department of Oncological Gastroenterology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw, Poland; Institute of Health and Society, University of Oslo, Oslo, Norway.

Editorial

Nastazja Dagny Pilonis et al. Gastrointest Endosc. 2022 May.

. 2022 May;95(5):954-955.

doi: 10.1016/j.gie.2021.12.044. Epub 2022 Mar 10.

¹ Department of Cancer Prevention and Department of Oncological Gastroenterology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw, Poland.
² Department of Cancer Prevention and Department of Oncological Gastroenterology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Gastroenterology, Hepatology and Oncology, Medical Center for Postgraduate Education, Warsaw, Poland; Institute of Health and Society, University of Oslo, Oslo, Norway.

No abstract available

Comment on

Implications of stable or increasing adenoma detection rate on the need for continuous measurement.
El Rahyel A, Vemulapalli KC, Lahr RE, Rex DK. El Rahyel A, et al. Gastrointest Endosc. 2022 May;95(5):948-953.e4. doi: 10.1016/j.gie.2021.10.017. Epub 2021 Oct 21. Gastrointest Endosc. 2022. PMID: 34687741